Aims-To determine whether mitral annular calcification and aortic valve calcification, with or without stenosis, are expressions of atherosclerotic disease. 
Mitral annulus calcification, aortic valve calcification, and calcific aortic valve stenosis represent a degenerative process that occurs mainly in the elderly. Calcific deposits lead to cardiac conduction disturbances in these patients, 1 2 or to embolism due to dislodgement of calcified material in the blood stream. The degenerative mechanism may accelerate when mechanical stress on the valvar apparatus is increased in hypertension and congenital or acquired valvar disorders. Prevalence of mitral annulus calcification and aortic valve calcification increases with age and often the conditions coexist. 3 Therefore the question arises as to whether the valvar calcifications are the result of increased valvar stress (as is the case in hypertension), an expression of more generalised atherosclerosis, or reflect a primary degenerative process, progressing with advancing age. Among the reports that suggest an association of mitral annulus and aortic valve calcification with cardiac and vascular risk factors is one population based study of 162 patients with mitral annulus calcification, which describes a multiple logistic regression model containing clinical risk factors. 4 We analysed whether there is a significant association of calcification of the mitral annulus or aortic valve with specific clinical and echocardiographic risk factors for generalised atherosclerotic disease.
Methods
The study population was recruited from a specially designed prospective echocardiographic database of 8160 consecutive patients examined between 1 January 1985 and 1 January 1990 at the department of cardiology of the University Hospital of Maastricht. The purpose and design of this registry is described elsewhere. 5 All patients with mitral annulus calcification or aortic valve calcification were selected for analysis of concomitant vascular risk factors. Risk factors were also studied in the control group, which was a randomly selected sample of 562 patients from the remaining patients without aortic valve or mitral annular calcification in the same database. Study and control patients were consecutive ambulatory or inpatients referred for echocardiography. Indications for echocardiography did not diVer between patients and controls. The University Hospital is the only hospital in the region. Therefore indications for referral to the hospital, as well as those for echocardiography, were representative of a university cardiology practice. In none of the patients or controls was suspicion of mitral annulus calcification or aortic valve calcification a reason for echocardiography, or for referral to the hospital. The following risk factors were recorded: age, sex, hypertension (known hypertension treated with antihypertensive drugs, two or more blood pressure recordings greater than 160/90 mm Hg), diabetes mellitus (known diabetes treated with diet or drugs or both; or either a fasting serum glucose of more than 7 mmol/l, or a postprandial serum glucose of more than 11 mmol/l measured on at least two separate occasions), ischaemic heart disease (myocardial infarction, angina pectoris), coronary artery bypass grafting, oral anticoagulants or salicylates, previous stroke or transient ischaemic attacks, serum cholesterol (the mean of all available measurements with or without treatment with cholesterol lowering drugs), hypercholesterolaemia (known treated hypercholesterolaemia or fasting or non-fasting serum cholesterol concentrations higher than 6.5 mmol/l), symptomatic peripheral arteriosclerotic disease (that is, intermittent claudication), and atrial fibrillation. For convenience, preventive measures are also considered as risk factors in the text and tables. Among other factors, the following echocardiographic variables were recorded: aortic valve calcification (defined as bright dense echoes of > 1 mm size on one or more cusps and decreased mobility of the involved cusp; if Doppler velocity was less than 2 m/s, measured with continuous Doppler, flow was considered to be within normal limits); calcific aortic valve stenosis (defined as having a maximum pressure gradient exceeding 16 mm Hg); mitral annulus calcification (defined as bright echoes in mitral annulus on two dimensional echocardiogram with "stone shadow"); mitral stenosis (defined as rheumatic mitral stenosis with increased velocities over the valve and a mitral valve area < 2.5 cm 2 , or non-rheumatic valvar disease if mitral annulus calcification and fibrosis caused a more than physiological gradient and a mitral valve orifice < 2.5 cm 2 ); mitral regurgitation; enlarged left atrium (diameter 45 mm or more); cardiac valve prosthesis. The rationale for including these variables in the study model was to search for associations between calcified cardiac valves and risk factors for atherosclerosis, or other cardiac findings suggested in previous studies.
STATISTICS
Statistical analysis was done with stepwise multiple logistic regression analysis with mitral annulus calcification, aortic valve calcification, and calcified aortic valve with stenosis, respectively, as dependent variables, and the control group as reference. The clinical and echocardiographic variables listed above could be entered into the model when the p level of entrance was 0.10 or lower. A study of mitral annulus calcification 4 showed an association with age, female sex, hypertension, and an enlarged left atrium, and on univariate analysis also with atrial fibrillation and aortic stenosis. We found a high prevalence of aortic valve calcification (43%) and calcific aortic valve stenosis (17%) in patients with mitral annulus calcification. However, there was no significant association between aortic valve calcification, calcific aortic valve stenosis, and mitral annulus calcification after adjusting for risk factors, and therefore this concomitance may be completely explained by common vascular risk factors in patients with these conditions. Atrial fibrillation was more frequent in our control group than in that of the population based Framingham study, which may explain why we did not find an association between mitral annulus calcification and atrial fibrillation. However, the higher percentage of atrial fibrillation among patients with mitral annulus calcification in the latter study may represent a higher incidence of cardiovascular risk factors, especially enlarged left atrium, and possibly age, which were not adjusted for in the analysis. 4 DiVerences between the Framingham study and our own study in the association of mitral annulus calcification with diabetes mellitus and hypercholesterolaemia may be explained by our definitions, which resulted in treated patients being considered as having the condition. Six other studies have reported cardiovascular risk factor profiles in patients with mitral annulus calcification, but using univariate models in age and sex matched patients, not adjusted for concomitant vascular risk factors. [6] [7] [8] [9] [10] [11] Why mitral annulus calcification prevails in women is unclear, although a role of increased serum parathyroid hormone resulting in hypovitaminosis D has been proposed. 12 AORTIC VALVE CALCIFICATION Epidemiological data about risk factors for aortic valve calcification are not available. Patients with calcific aortic valve stenosis more often had angina pectoris, hypertension, or sudden cardiac death, 13 or cardiac conduction disorders. 1 2 Our findings are in agreement with Roberts, 3 14 who stated that factors predisposing to atherosclerosis also predispose to aortic valve calcification. CONCLUSION We have shown that mitral annular and aortic valve calcification have similar cardiac and vascular risk factors and should be regarded as comparable expressions of underlying age related cardiac manifestations of atherosclerosis.
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